NVAX vs SCHW · P/E 2.5, rev $196.2M vs P/E 19, rev $13.55B
Novavax Inc (NVAX) versus Charles Schwab Corp (SCHW) — a side-by-side from cached financials, not a winner call.
Novavax Inc (NVAX) is a biotechnology company listed on US.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Richard Andrew Wurster C.F.A., CMT.
Latest reported NVAX revenue for 2026-06-30 was $196.2M. Net income was -$62.9M. Revenue was up 40.6% from 2026-03-31 to 2026-06-30. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
Latest reported SCHW revenue for 2026-06-30 was $13.55B. Net income was $5.28B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
NVAX currently screens at market cap $1.09B and trailing P/E 2.5. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Not investment advice. Open the NVAX and SCHW stock pages for the full models.
Not investment advice.